Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
2401
DELISTED
Blueprint Medicines
BPMC
| $13M | ﹤0.01% |
289,055
+65,633
| +29% | +$2.96M |
|
2402
American Financial Group
AFG
$12.1B
| $13M | ﹤0.01% |
107,030
+78,668
| +277% | +$10.4M |
|
2403
DoubleVerify
DV
$2.04B
| $13M | ﹤0.01% |
430,901
-804,800
| -65% | -$21.1M |
|
2404
Ascendis Pharma A/S
ASND
$16.3B
| $13M | ﹤0.01% |
121,002
-135,284
| -53% | -$15.5M |
|
|
MRO
2405
DELISTED
Marathon Oil Corporation
MRO
| $13M | ﹤0.01% |
540,704
-2,088,145
| -79% | -$53.4M |
|
2406
PUT
Credit Acceptance
CACC
$6.1B
| $13M | ﹤0.01% |
29,700
| – | – |
|
2407
PUT
Iron Mountain
IRM
$38.5B
| $12.9M | ﹤0.01% |
244,500
-8,400
| -3% | -$440K |
|
2408
PUT
GlobalFoundries
GFS
$30B
| $12.9M | ﹤0.01% |
179,000
-28,800
| -14% | -$1.82M |
|
|
FLNA
2409
PUT
Filana Therapeutics
FLNA
$44.1M
| $12.9M | ﹤0.01% |
535,400
+48,700
| +10% | +$1.35M |
|
|
DADA
2410
DELISTED
Dada Nexus
DADA
| $12.9M | ﹤0.01% |
1,524,205
+1,295,418
| +566% | +$14.1M |
|
|
RJAC
2411
DELISTED
Jackson Acquisition Company
RJAC
| $12.9M | ﹤0.01% |
1,251,499
-144
| -0% | -$1.47K |
|
2412
Oscar Health
OSCR
$10.1B
| $12.9M | ﹤0.01% |
1,970,046
+1,939,578
| +6,366% | +$7.92M |
|
2413
PUT
Murphy Oil
MUR
$4.96B
| $12.8M | ﹤0.01% |
347,300
+117,600
| +51% | +$4.7M |
|
2414
CALL
Corpay
CPAY
$27.4B
| $12.8M | ﹤0.01% |
60,900
-40,300
| -40% | -$8.18M |
|
|
ABB
2415
DELISTED
ABB Ltd
ABB
| $12.8M | ﹤0.01% |
373,774
+97,627
| +35% | +$3.27M |
|
2416
Frontier Group Holdings
ULCC
$1.54B
| $12.8M | ﹤0.01% |
1,302,493
+543,783
| +72% | +$6.07M |
|
|
SVC
2417
Service Properties Trust
SVC
$1.05B
| $12.8M | ﹤0.01% |
257,201
+54,250
| +27% | +$2.51M |
|
2418
Unity
U
$20.4B
| $12.8M | ﹤0.01% |
394,834
+253,572
| +180% | +$8.16M |
|
2419
CALL
ProShares Ultra Bloomberg Crude Oil
UCO
$430M
| $12.8M | ﹤0.01% |
483,500
-119,800
| -20% | -$3.27M |
|
2420
Rithm Capital
RITM
$5.79B
| $12.8M | ﹤0.01% |
1,599,409
+754,941
| +89% | +$6.64M |
|
|
GAP
2421
PUT
The Gap Inc
GAP
$7.42B
| $12.8M | ﹤0.01% |
1,274,300
-232,200
| -15% | -$2.83M |
|
2422
PUT
Robinhood
HOOD
$85.9B
| $12.8M | ﹤0.01% |
1,315,300
-1,878,500
| -59% | -$17.9M |
|
|
AGEN
2423
Agenus
AGEN
$329M
| $12.7M | ﹤0.01% |
425,565
+372,488
| +702% | +$15.7M |
|
|
RETA
2424
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $12.7M | ﹤0.01% |
139,600
-57,400
| -29% | -$3.37M |
|
|
2425
Credit Acceptance
CACC
$6.1B
| $12.7M | ﹤0.01% |
29,106
-60,652
| -68% | -$26.7M |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.